Volume | 178,516 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | 0.7999 | Mínimo Máximo |
|||||
Minimo del Dia | 0.75 |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
ABVC BioPharma Inc | ABVC | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
0.7656 | 0.75 | 0.7999 | 0.777 | 0.789 |
Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
---|---|---|---|---|---|
1,177 | 178,516 | US$ 0.7665498 | US$ 136,841 | - | 0.6739 - 6.98 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
17:58:27 | formt | 100 | US$ 0.7503 | USD |
Información Financiera ABVC BioPharma Inc ABVC
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
8.24M | 10.56M | - | 152k | -10.52M | -1.00 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre ABVC BioPharma Inc ABVC
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
24/5/2024 | 07:00 | Edgar (US Regulatory) | Form 8-K - Current report |
23/5/2024 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
23/5/2024 | 15:30 | Edgar (US Regulatory) | Form 424B4 - Prospectus [Rule 424(b)(4)] |
22/5/2024 | 16:00 | Edgar (US Regulatory) | Form 424B4 - Prospectus [Rule 424(b)(4)] |
22/5/2024 | 13:31 | Edgar (US Regulatory) | Form 424B4 - Prospectus [Rule 424(b)(4)] |
17/5/2024 | 16:00 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] |
17/5/2024 | 15:01 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
15/5/2024 | 16:00 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form.. |
15/5/2024 | 08:00 | Edgar (US Regulatory) | Form 8-K - Current report |
09/5/2024 | 08:27 | Edgar (US Regulatory) | Form 8-K - Current report |
18/4/2024 | 08:25 | GlobeNewswire Inc. | AiBtl BioPharma Inc. Acquired TT Life Company, Valued at.. |
17/4/2024 | 08:00 | GlobeNewswire Inc. | ABVC BioPharma Executes a Global Licensing Definitive.. |
Histórico de Datos ABVC
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.85 | 0.8501 | 0.75 | 0.7834423 | 152,122 | -0.0997 | -11.73% |
1 Month | 1.08 | 1.14 | 0.75 | 0.966805 | 186,009 | -0.3297 | -30.53% |
3 Months | 1.21 | 1.73 | 0.75 | 1.29 | 1,243,465 | -0.4597 | -37.99% |
6 Months | 1.33 | 2.45 | 0.75 | 1.61 | 1,473,805 | -0.5797 | -43.59% |
1 Year | 6.30 | 6.98 | 0.6739 | 1.92 | 1,580,694 | -5.55 | -88.09% |
3 Years | 33.20 | 116.883 | 0.6739 | 17.55 | 997,963 | -32.45 | -97.74% |
5 Years | 33.20 | 116.883 | 0.6739 | 17.55 | 997,963 | -32.45 | -97.74% |